Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

Hives (urticaria) are a common skin reaction that causes bumps, raised patches, or both. They are one way the body responds to an allergen or trigger. Reactions can be uncomfortable but aren’t ...

Aims To describe and compare clinical features, complications and outcomes in patients with granulomatosis with polyangiitis (GPA)-associated scleritis with those seen in idiopathic and other ...